F-18 FDG PET/CT Finding in Solid Pseudo-papillary Tumor of the Pancreas 6 years After Initial Diagnosis

Byung-Wook CHOI; Hae-Won KIM; Kyoung-Sook WON; Seok-Kil ZEON.
Nuclear Medicine and Molecular Imaging ; : 577-581, 2009.
Artículo en Ko | WPRIM | ID: wpr-198896

Documentos relacionados

  1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  2. Heavy Metal Enlightens Tumor Immunity.
  3. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  4. Molecular differences in renal cell carcinoma between males and females.
  5. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
  6. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
  7. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
  8. Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
  9. Renal cell carcinoma, part 1.
  10. Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.